SWK Holdings Corporation (SWKH)

Over the past six months, a significant event was the announcement on October 9, 2025, that Runway Growth Finance Corp. intends to acquire SWK Holdings Corporation, expected to close in late 2025 or the first quarter of 2026. SWK issued its Q3 2025 earnings on November 6, 2025, reporting an EPS of $0.59, surpassing analysts' estimates. The share price as of January 30, 2026, was $17.50, representing a 6.71% increase from February 3, 2025.

Based on the available information, there is no specific data indicating significant demand seasonality for SWK Holdings Corp.'s financial services or pharmaceutical development products. Revenue fluctuations are attributed to growth and specific milestone achievements rather than recurring seasonal trends.

SWK Holdings Corporation is a life science-focused specialty finance company that partners with small and mid-sized commercial-stage healthcare companies, providing non-dilutive financing solutions. The company also owns Enteris BioPharma, a clinical development and manufacturing organization offering development services and innovative formulation solutions.

SWK Holdings Corporation is headquartered in Dallas, Texas, and focuses on opportunities within the global healthcare sector, providing capital solutions to a broad range of life science companies, institutions, and inventors.

SWK Holdings maintains a positive brand reputation, with partners describing SWK as a "perfect partner" providing tailored solutions and a "strong and professional partner" throughout diligence, negotiation, and successful exits. Partners have also highlighted SWK's thorough understanding of their businesses and the industry, providing flexible capital solutions that facilitate growth.

SWK Holdings Corporation has a substantial institutional ownership base, with 129 institutional owners and shareholders holding a total of 10,858,168 shares. Major institutional owners include Carlson Capital L P, M3F, Inc., Cannell Capital Llc, Vanguard Group Inc, and BlackRock, Inc. Carlson Capital L.P. holds a significant portion of equities.